» Articles » PMID: 21221599

Uncontrolled Home Blood Pressure in the Morning is Associated with Nephropathy in Japanese Type 2 Diabetes

Abstract

The purposes of this study were to investigate the state of blood pressure control level and to investigate the relationship between blood pressure control level and nephropathy in Japanese type 2 diabetes. We measured clinic and home blood pressure in 923 type 2 diabetic patients. According to the criteria for hypertension in the Japanese Society of Hypertension Guidelines 2009, patients were classified into four groups by clinic systolic blood pressure (130 mmHg) and morning systolic blood pressure (125 mmHg), as follows: controlled hypertension (CH), white-coat hypertension (WCH), masked hypertension (MH), and sustained hypertension (SH). Of all patients, 13.9, 12.6, 13.3, and 60.2% were identified as having CH, WCH, MH, and SH, respectively. The average number of drugs prescribed was 1.8. We assessed the association between blood pressure control level and nephropathy in diabetic patients. The degree of urinary albumin excretion and the prevalence of nephropathy in diabetic patients were higher in MH and SH groups than those in the CH group. The majority of patients had poor blood pressure control, regardless of ongoing conventional antihypertensive therapy, and diabetic patients with MH and SH were associated with nephropathy. It is suggested that more aggressive antihypertensive treatment is recommended to prevent nephropathy in diabetic patients.

Citing Articles

Impact of continued high blood pressure on the progression of diabetic nephropathy after 10 years: KAMOGAWA-HBP study.

Hata S, Ushigome E, Hosomi Y, Yoshimura T, Takegami M, Kitagawa N Hypertens Res. 2023; 46(3):565-574.

PMID: 36631553 DOI: 10.1038/s41440-022-01136-3.


Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with type 2 diabetes mellitus.

Kitagawa N, Ushigome E, Kitagawa N, Ushigome H, Yokota I, Nakanishi N Diab Vasc Dis Res. 2022; 19(3):14791641221098193.

PMID: 35538651 PMC: 9102143. DOI: 10.1177/14791641221098193.


Impact of Isolated High Home Systolic Blood Pressure and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A 5-Year Prospective Cohort Study.

Kitagawa N, Kitagawa N, Ushigome E, Ushigome H, Yokota I, Nakanishi N J Clin Med. 2021; 10(9).

PMID: 33946928 PMC: 8124698. DOI: 10.3390/jcm10091929.


Effects of dietary salt restriction on home blood pressure in diabetic patients with excessive salt intake: a pilot study.

Ushigome E, Oyabu C, Iwai K, Kitagawa N, Kitae A, Kimura T J Clin Biochem Nutr. 2019; 65(3):252-257.

PMID: 31777428 PMC: 6877400. DOI: 10.3164/jcbn.19-61.


Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study.

Okamura T, Ushigome E, Kitagawa N, Oyabu C, Tanaka T, Hasegawa G J Diabetes Investig. 2019; 10(6):1543-1549.

PMID: 30884176 PMC: 6825917. DOI: 10.1111/jdi.13040.


References
1.
Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

2.
Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S . Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens. 2006; 19(9):880-6. DOI: 10.1016/j.amjhyper.2006.03.006. View

3.
Omae K, Ogawa T, Nitta K . Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease. Heart Vessels. 2010; 25(3):203-8. DOI: 10.1007/s00380-009-1188-4. View

4.
Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B . Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004; 291(11):1342-9. DOI: 10.1001/jama.291.11.1342. View

5.
Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19):2560-72. DOI: 10.1001/jama.289.19.2560. View